Eiger – Talk Bio

Amylyx Acquires GLP-1 Receptor Antagonist for $35M to Fill Pipeline Gap

10 months ago talkbio0Tagged Amylyx, Amyotrophic Lateral Sclerosis, Biopharma, Eiger, expansion, GLP-1 receptor antagonist, pipeline, Relyvrio, Wolfram Syndrome

Amylyx Pharmaceuticals, Relyvrio, GLP-1 receptor antagonist, Eiger Biopharma, pipeline expansion, ALS, Wolfram syndrome

Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm, and More Companies Reduce Workforce

1 year ago talkbio0Tagged Acorda, Biological Factors, Biopharma layoffs, Cara, Eiger, Fujifilm, Genomic Orientation, Invitae, Pfizer, sanofi, Vedanta

Biopharma layoffs, Sanofi, Vedanta, Fujifilm, Acorda Therapeutics, Eiger BioPharmaceuticals, Invitae, Sientra, Strand Therapeutics, Cara Therapeutics, Pfizer

Eiger BioPharmaceuticals Declares Bankruptcy and Announces Operational Wind Down Following Years of Challenges

1 year ago talkbio0Tagged Bankruptcy, Biological Factors, Chapter 11, Assets Sale, development aspects, Eiger, Infrequent, Metabolic Disease Therapy, Operational Wind Down

Eiger BioPharmaceuticals, Bankruptcy, Chapter 11, Assets Sale, Operational Wind Down, Rare Metabolic Disease Therapy Development